|Other Names||Bcl10-interacting CARD protein, BinCARD, C9orf89|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Plays a role in inhibiting the effects of BCL10-induced activation of NF-kappa-B. May inhibit the phosphorylation of BCL10 in a CARD-dependent manner.|
|Cellular Location||Isoform 1: Nucleus. Note=Coexpression with BCL10 induced translocation from nucleus to cytosol|
|Tissue Location||Expressed in ovary, testis, placenta, skeletal muscle, kidney, lung, heart and liver (at protein level) Expressed in thymus and brain.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
C9orf89 plays a role in inhibiting the effects of BCL10-induced activation of NF-kappa-B. May inhibit the phosphorylation of BCL10 in a CARD-dependent manner.
Matsuoka, S., et al. Science 316(5828):1160-1166(2007)Woo, H.N., et al. FEBS Lett. 578(3):239-244(2004)
If you have any additional inquiries please email technical services at email@example.com.